USA TODAY US Edition

BILL PLANNED IN RE­SPONSE TO EPIPEN PRIC­ING FUROR

- — Jayne O’Don­nell Business · U.S. News · United States Department of Health and Human Services · Tammy Baldwin · Wisconsin · Arizona · Illinois · John McCain · Jan Schakowsky

In the first leg­isla­tive re­sponse to the EpiPen pric­ing furor, a bi­par­ti­san group of Se­nate and House mem­bers plans to in­tro­duce a bill Thurs­day that would force drug mak­ers to tell the De­part­ment of Health and Hu­man Ser­vices why any price in­crease of more than 10% is jus­ti­fied at least a month be­fore the in­crease.

Com­pa­nies would have to dis­close spend­ing on re­search and de­vel­op­ment, man­u­fac­tur­ing, mar­ket­ing and ad­ver­tis­ing spend­ing on the drug, as well as profit in­for­ma­tion — and all but the con­fi­den­tial or pro­pri­etary de­tails would be made public.

That’s ac­cord­ing to the of­fice of Sen. Tammy Bald­win, D-Wis., a co-spon­sor of the Fair Ac­count­abil­ity and In­no­va­tive Re­search (FAIR) Drug Pric­ing Act.

Sen. John McCain, R-Ariz. is co-spon­sor­ing the leg­is­la­tion in the Se­nate and Rep. Jan Schakowsky, D-Ill., is the House cospon­sor, Bald­win’s of­fice said.

Newspapers in English

Newspapers from USA